Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
By the end of this webinar, attendees should...
1. Be able to articulate why it’s important to consider a patient community audience when planning scientific and data dissemination including incorporating their voice within it.
2. Be confident to follow clear methodologies to incorporate the patient voice within publications and the role of Medical Affairs in disease awareness campaigns.
3. Be able to implement best practice approaches including novel ways to disseminate information.
Through our lens into real-world issues that affect equitable use of industry innovations, Medical Affairs can drive the transformation of industry from a drug-centric perspective to a patient-centric perspective. This article discusses a few of these opportunities.
This webinar will focus on the role of Medical Affairs to lead patient engagement in clinical development.
Health literacy is experiencing new challenges, and Medical Affairs is uniquely positioned to lead and partner with others in this space to ensure coordination, credibility and impact.
MEDICAL AFFAIRS: The Roles, Value and Practice of Medical Affairs in the Biopharmaceutical and Medical Technology Industries (Taylor & Francis, 2024)
MAPS speaks with Liz de Somer, CEO of Medicines Australia and Sharon Winton, CEO of Lymphoma Australia to explore patient engagement from the perspectives of industry and patient associations.
The MAPS Patient Centricity FAWG surveyed Medical Affairs community, including MAPS members, for their input on patient centricity initiatives within their respective organizations. We will be sharing insights from the recent MAPS Patient Centricity Survey on industry perspectives, including the major barriers to implementing initiatives that were identified in the survey. Our experts will be providing guidance and potential solutions on addressing major barriers for patient centricity initiatives identified through the survey.
This paper provides a vision describing how Gen AI technologies will reshape the possibilities and practice of Medical Affairs related to the four functional pillars of Strategy & Leadership, Evidence & Insights Generation, Evidence & Insights Communication, and Engagement & Partnerships.
The Medical community knows it needs to improve equity in clinical trials, but what really helps when it comes to changing patient and provider perceptions? PlatformQ Health is pleased to share insights into strategies for helping patients become more receptive to trial participation and supporting providers in fostering inclusion.
While the value of patient engagement is increasingly recognised in the clinical and launch phases of drug development, it is still a relatively new concept to involve patients in the early discovery phase. By understanding the burden of disease and patient’s aspirations for new treatments from the outset, pharma companies can ensure they are developing medicines that matter to patients. As experts in the disease area and therapeutic landscape, Medical Affairs are well placed to initiate and develop effective patient partnerships to ensure that the patient voice is incorporated during early discovery and beyond.
In this webinar we will explore practical approaches to engaging patients in early development, introducing key resources and discussing best practices. These discussions will be tailored to meet the needs of all Medical Affairs colleagues, regardless of experience.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.